No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6959715 |
chr7:39123165-39123166 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs370451599 |
chr7:39123225-39123226 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs16880005 |
chr7:39123257-39123258 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs181429806 |
chr7:39123265-39123266 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs376730416 |
chr7:39123285-39123286 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs572299899 |
chr7:39123324-39123325 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs17171531 |
chr7:39123325-39123326 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs368368140 |
chr7:39123426-39123427 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs2177799 |
chr7:39123438-39123439 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs111998962 |
chr7:39123509-39123510 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs564029369 |
chr7:39123531-39123532 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs532972413 |
chr7:39123622-39123623 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs116327115 |
chr7:39123627-39123628 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs371166237 |
chr7:39123642-39123643 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs563350113 |
chr7:39123648-39123649 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs530934654 |
chr7:39123652-39123653 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs141552061 |
chr7:39123688-39123689 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs150908034 |
chr7:39123693-39123694 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs568609506 |
chr7:39123699-39123700 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs535172711 |
chr7:39123714-39123715 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs534460779 |
chr7:39123780-39123781 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs36065581 |
chr7:39123852-39123853 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs570480533 |
chr7:39123975-39123976 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs539472850 |
chr7:39123996-39123997 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs185962558 |
chr7:39124021-39124022 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs77220763 |
chr7:39124042-39124043 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs576116571 |
chr7:39124043-39124044 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs190610313 |
chr7:39124058-39124059 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs570502617 |
chr7:39124073-39124074 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs79756471 |
chr7:39124101-39124102 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs182477731 |
chr7:39124105-39124106 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs543855152 |
chr7:39124195-39124196 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs185637169 |
chr7:39124215-39124216 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs375307372 |
chr7:39124216-39124217 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs564393007 |
chr7:39124283-39124284 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs78116367 |
chr7:39124314-39124315 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs190592150 |
chr7:39124339-39124340 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs182884525 |
chr7:39124363-39124364 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs10254198 |
chr7:39124375-39124376 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs368083463 |
chr7:39124420-39124421 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs17171532 |
chr7:39124426-39124427 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs372094597 |
chr7:39124461-39124462 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs73373258 |
chr7:39124500-39124501 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs562270962 |
chr7:39124501-39124502 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs527897336 |
chr7:39124586-39124587 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs188636851 |
chr7:39124661-39124662 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs570791020 |
chr7:39124664-39124665 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs576305872 |
chr7:39124669-39124670 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs193274866 |
chr7:39124691-39124692 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs17431633 |
chr7:39124704-39124705 |
Weak transcription Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|